Many pharma manufacturers still check the resilience of their packaging manually. That is not efficient to guarantee a maximum product protection, smooth integration of the packaging solution into production processes and a fast time-to-market. Win insights in this article how Körber enables its pharma customers to examine the optimal product protection of their secondary packaging by using recognized pre-tests during the qualification phase to accelerate product launches and avoid additional costs.
Manual drop tests from the table are not the best way to examine the product protection of pharma secondary packaging. Failing to pass the strict & mandatory shipment tests can result in project delays of three months and even more. What if you could shorten the development process of your pharma packaging by testing it at any stage? And get immediate & concrete recommendations for adjustments?
That’s exactly what Körber offers with its new Packaging Qualification Service: "We can give our customers the opportunity to quickly and flexibly test a wide range of properties and behaviors of their folding boxes and to draw valuable conclusions for the optimization of their packaging", explains Patric Buck, Head of Innovation Packaging Materials in Körber‘s Pharma Business Area. "This saves them the sometimes very time-consuming search for available external testing laboratories." Körber offers this service regardless of whether the folding boxes have been developed in-house or by another provider.
